In addition, LPAR2 associates with T2DM [217] suggesting that ATX/LPA through LPAR2 may be involved in NAFLD severity and its progression to HCC in a diabetic background. Here, LPAR2 is linked to metabolic dysfunction-associated steatotic liver disease.